An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
about
Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53HER-2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies.Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.The future of prognostic factors in outcome prediction for patients with cancer.Breast cancer and a proto-oncogene.Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer.Prognostic significance of c-erbB-2 expression in node negative breast cancerbcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.Human breast cancer: identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB-2 overexpressionThe long term prognostic significance of c-erbB-2 in primary breast cancerc-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.c-erbB-2 oncoprotein expression in primary and advanced breast cancerThe relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancerDistribution of c-yes-1 gene product in various cells and tissues.c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.Response to treatment of breast cancer.Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancerAn evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.c-erbB-2 expression in different histological types of invasive breast carcinoma.Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor.c-erbB-2 expression in FNAB smears and matched surgical specimens of breast cancer.Prognostic association of c-erbB-2 oncogene amplification and protein overexpression in human breast cancer using archival tissues. A comparative study.Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors.Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11.Genetic alterations in primary breast cancer.Biological indices in the assessment of breast cancer.Prognostic factors in breast cancer: use of cytologic preparations.New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.Rat monoclonal antibodies to the external domain of the product of the C-erbB-2 proto-oncogene.c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study.c-erbB-2 oncogene as a prognostic marker in breast cancer.C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma.Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer.
P2860
Q28363615-15D0FC13-C73A-424C-9348-C39E43A14728Q33631562-51BBE783-3DB5-4293-86B6-511B7737D483Q33970193-B0754F43-D6D8-49F9-9EB5-09213FD4D8BFQ34602545-F95F3FAE-9A9A-48DA-B74C-EBF563F2A0A6Q35368684-788C2E18-8407-4787-9E6A-720413D28386Q35718067-631E057A-215C-43FF-A354-8AB07952F80BQ35898678-6CDC6903-4759-4D88-930E-6119F4E5FA77Q35976044-3262F53E-2F3D-4CE1-8778-FD8B0B810D8DQ35977975-59160053-351D-4573-BBF3-F2C3DDCEBCB9Q35981979-2ACEB9A3-44FF-4753-BFAB-ECF041B9F637Q35983210-0635A112-A6AA-47DB-8D74-030F31FB1B59Q35983237-458EF064-0D0E-47F3-8299-C008FADCF36DQ35983286-FD237AA6-F1A7-4F71-A96F-EC37D93C65FCQ35983317-A99DDDD8-27BB-4F9A-853B-B2B594FF5C24Q35984225-8DC5F19F-9817-4DB8-B598-A30F27534649Q35993223-27564ECF-6CD2-46D8-9BB9-C2FA1DC15719Q36414303-31C33933-001A-44D1-A71C-FAE851B74AFCQ36431192-16DBAAD5-61DF-4B29-AFBE-7F9C1AEA32EFQ36467701-8817E4B5-DC9A-4791-B031-1AB2386B23A7Q36609893-BB67E36E-B4A1-49F3-9A3C-451FBBA2E4BEQ36617556-B709DE25-8746-4E91-9179-2D0A1DD77903Q37111228-8CAE1267-ED1C-480E-90FE-B10278EA99C1Q37119722-B921ED8C-5EA7-456A-A240-4FCFFD6AA164Q37143922-3428356C-66D9-4B46-80E9-75A278BD9E29Q37586533-5334212D-3C07-42B3-9A40-9029BDD542D7Q38478519-C1E5542D-257E-4E05-BA4A-09EFBD4B7432Q38484552-5D53261A-3D34-4C87-A8DF-3A1810ABA1F8Q38488717-77C64220-B6FB-40FB-AE78-3EA15E4BA9A1Q38489173-1EC160B9-FF67-4925-A391-093F664A9DE6Q38671576-A5FDEF60-9760-4B3F-8117-CBAB753FB016Q40848953-16B7FF37-B1A4-4A08-A863-6BD27F188C78Q41134041-8469D3FF-684D-479D-8946-BBC03836D041Q41702637-142E6328-3E83-49BA-BAE0-AFDF653D3BD1Q41744043-369A6CC4-2B1C-4E91-B79F-9F0FBE1153D8Q41885197-2EBC894A-0F5E-426C-87CF-144EED81FDB8Q42009098-744AD243-6491-4425-B343-2FD6C8A2D615Q42383432-D2042D71-6985-4C74-B922-8D01F163D07DQ42384421-8CCC7E1C-372E-4B8F-8E4D-6D85DF8FF321Q43759908-C0D73C44-BA6A-47B1-BFAA-5E3DF68B1721Q43787651-15DA6330-9E98-497B-BDDC-CC33B596F25A
P2860
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
@ast
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
@en
type
label
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
@ast
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
@en
prefLabel
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
@ast
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
@en
P2093
P2860
P356
P1476
An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1988.238
P407
P577
1988-10-01T00:00:00Z
P5875
P6179
1040685055